Insufficient substrate supply may cap AMD's growth because the company has not secured enough capacity. The author says limited substrate availability drove AMD's lowered guidance, making supply-chain execution the constraint on how far it can grow. This adds an execution risk to the earlier concern that AMD is too expensive to buy despite strong results. x.com x.com

